arrow
M

Michael Huber

University of Zurich
H指数:41
被引数:7,426

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pretreatment Resistance to Integrase Inhibitors in the Swiss HIV Cohort Study From 1995 to 2025

瑞士艾滋病队列研究(1995年至2025年)中整合酶抑制剂的初始耐药情况

2026-07-170
OA
Viral metagenomic sequencing reveals rare pathogens and improves diagnostic accuracy in neuroinflammatory disorders

病毒宏基因组测序揭示了罕见病原体,并提高了神经炎症性疾病的诊断准确性。Diagn. Microbiol. Infect. Dis. 114, 117140

2025-10-011
OAAI
Emergence of Bictegravir Resistance in a Treatment-Experienced PWH on Functional Monotherapy and Rapid Replacement by an Ancient Wild-Type Strain Following Transient Treatment Interruption

Bictegravir耐药性在一名接受功能单药治疗的治疗经验性人类免疫缺陷病毒感染者中的出现,以及短暂治疗中断后古老野生型株的快速替代。

2025-05-130
OA
Multicenter benchmarking of short and long read wet lab protocols for clinical viral metagenomics

临床病毒宏基因组学的短期和长期阅读湿实验室方案的多中心基准测试

2024-08-013
OAAI
Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association study
2024-05-310
OAAI
How much should we sequence? An analysis of the Swiss SARS-CoV-2 surveillance effort
2024-05-021
OAAI
No Remdesivir Resistance Observed in the Phase 3 Severe and Moderate COVID-19 SIMPLE Trials
2024-03-312
OAAI
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

交叉保护性HCoV免疫可减少SARS-CoV-2感染期间的症状发展

MBIO
IF4.7
2024-02-142
OAAI
Deciphering Factors Linked With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Susceptibility in the Swiss HIV Cohort Study
2024-01-160
OAAI
The Swiss Pathogen Surveillance Platform-towards a nation-wide One Health data exchange platform for bacterial, viral and fungal genomics and associated metadata
2023-05-1214
OAAI